RXRX
RECURSION PHARMACEUTICALS-AData as of 2026 Q2 (06-30) · 13F snapshot
Summary
RECURSION PHARMACEUTICALS-A (RXRX) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$159.05M; the largest are Cathie Wood, Izzy Englander, Ken Griffin. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 1 added, 2 trimmed, 2 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders42 also report options
Congress trades0
Price$3.70vs quarter-end+0.82%
Sectors1
This quarter's moves
Top holderNew1
Added1
Trimmed / sold4
Cathie WoodCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $4.78M— of portfolio1,302,4002026 Q2
Value $4.07M— of portfolio1,109,6002026 Q2
Value $1.59M— of portfolio433,6002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $4.78M | — | — |
| Ken GriffinPUT | $4.07M | — | — |
| Paul Tudor JonesCALL | $1.59M | — | — |
ARK ETF holdings
Cathie Wood · dailyARK total shares held · drag to inspect
2026-09-29holds 38,621,100
- ARKGweight in fund2.34%$51.03M
- ARKKweight in fund1.07%$91.87M
ARK publishes full ETF holdings daily (SEC Rule 6c-11). Line shows ARK's total shares held over time (not price); markers are buy/sell days. Derived from public CSVs — research only, not investment advice.
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.